Biotech

All Articles

AstraZeneca pays for CSPC $100M for preclinical heart disease medication

.AstraZeneca has settled CSPC Drug Group $100 million for a preclinical heart disease drug. The offe...

Zephyrm seeks Hong Kong IPO to cash phase 3 cell treatment tests

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, submission (PDF) for an...

Frazier Lifestyle Sciences gathers $630M for tiny, mid-cap biotechs

.Frazier Life Sciences has sourced an even more $630 million for its fund concentrated on small and ...

GigaGen gathers around $135M BARDA money to beat botulism

.Antibody fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its own t...

GPCR agency Septerna apply for IPO on toughness of preclinical information

.Septerna will learn just how a biotech without "any purposeful scientific records" fares in the lat...

Kurma closes initially $154M loot for largest biotech fund yet

.International VC organization Kurma Partners has actually revealed its own most up-to-date biotech ...

Prothena ensures one director while an additional leaves-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of significant management hirings, shootings an...

Editas exploit Tip Cas9 licensing rights for $57M

.Against the scenery of a Cas9 patent struggle that declines to die, Editas Medicine is moneying in ...

Ultragenyx changes genetics therapy dosing to call up effectiveness

.A minority of patients taking Ultragenyx Drug's Wilson condition gene therapy UX701 have actually c...

Biopharma cutback rate supports in Q3: Fierce Biotech review

.As summer months heat turns to cool down winds, wishes that this year would certainly carry prevale...